Melanie Mole
Adult Medicine · Easley, SCNPI 1093550014
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations.
Across 99 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$293
- AstraZeneca$276
- Axsome Therapeutics, Inc.$185
- Insmed, Inc.$182
- Verona Pharma, Inc.$164
- Amgen$142
- plus $770 from 12 others
What the payments were for
- Food & beverage$1,94297%
- Education$693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 14 | $293 |
| AstraZeneca | 12 | $276 |
| Axsome Therapeutics, Inc. | 9 | $185 |
| Insmed, Inc. | 9 | $182 |
| Verona Pharma, Inc. | 10 | $164 |
| Amgen | 15 | $142 |
| Merck | 5 | $134 |
| Jazz Pharmaceuticals Inc. | 3 | $121 |
| United Therapeutics Corporation | 3 | $101 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $91 |
| Sanofi | 4 | $86 |
| Actelion Pharmaceuticals US, Inc. | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Harmony Biosciences LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $21 |
| Liquidia Technologies, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
How this compares
Too few adult medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $3,789 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $413 |
| Lorazepam | 25 | $375 |
| Atorvastatin Calcium | 12 | $157 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Easley
- Alfred MossGaffney$14K
- Katherine PeilSumter$8K
- Jose Morales VazquezMyrtle Beach$2K
- Elaine Inman-WilliamsonAiken$2K
- Samai SupanOkatie$713
- Yvette-Marie PellegrinoBeaufort$635
- Kelly PassarelloSummerville$482
- Kelley MoodyHartsville$290
- Kelsey SeptimioFort Mill$229
- Samuel OrrGaffney$157
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.